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Angiogenesis is a highly ordered physiological process regulated by the interaction
of endothelial cells with an extensive variety of growth factors, extracellular matrix
components and mechanical stimuli. One of the most important challenges in tissue
engineering is the rapid neovascularization of constructs to ensure their survival after
transplantation. To achieve this, the use of pro-angiogenic agents is a widely accepted
approach. The study of angiogenesis has gained momentum over the last two decades.
Although there are various in vitro, ex vivo, and in vivo angiogenesis models that
enable testing of newly discovered pro-angiogenic agents, the problem with researching
angiogenesis is the choice of the most appropriate assay. In vivo assays are the most
representative and reliable models, but they are expensive, time-consuming and can
cause ethical concerns whereas in vitro assays are relatively inexpensive, practical,
and reproducible, but they are usually lack of enabling the study of more than one
aspect of angiogenesis, and they do not fully represent the complexity of physiological
angiogenesis. Therefore, there is a need for the development of an angiogenesis model
that allows the study of angiogenesis under physiologically more relevant, dynamic
conditions without causing ethical concerns. Accordingly, in this study, we developed
3D in vitro dynamic angiogenesis model, and we tested the angiogenic potential
of 2-deoxy-D-ribose (2dDR) in comparison with vascular endothelial growth factor
(VEGF) using newly developed in vitro 3D dynamic model and well-established in vitro
models. Our results obtained using conventional in vitro assays demonstrated that 2dDR
promoted proliferation, migration and tube formation of human aortic endothelial cells
(HAECs) in a dose-dependent manner. Then, the angiogenic activity of 2dDR was further
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assessed using the newly developed 3D in vitro model, which enabled the monitoring
of cell proliferation and infiltration simultaneously under dynamic conditions. Our results
showed that the administration of 2dDR and VEGF significantly enhanced the outgrowth
of HAECs and the cellular density under either static or dynamic conditions.
Keywords: angiogenesis, vascular endothelial growth factor (VEGF), 2-deoxy-D-ribose (2dDR), thymidine
phosphorylase (TP), angiogenesis assays, shear stress, emulsion templating, PolyHIPE
INTRODUCTION
Angiogenesis is a complex process driven by the interactions of
endothelial cells (ECs) with growth factors, extracellular matrix,
and mechanical stimuli (Risau, 1997). Delayed angiogenesis
of tissue-engineered (TE) constructs is a major challenge for
their translation to the clinic (Novosel et al., 2011). One
approach is the use of pro-angiogenic agents to circumvent
slow neovascularization. Thus, researchers have been exploring
pro-angiogenic agents to ensure rapid neovascularization in
tissue engineering constructs using well-established in vitro and
in vivomodels.
Vascular endothelial growth factor (VEGF) is a well-known
stimulator of angiogenesis and recognized as the most effective
pro-angiogenic factor both in vitro and in vivo (Ferrara, 2009).
However, several studies showed that the administration of
VEGF in an uncontrolled manner might cause excessively leaky
(Yancopoulos et al., 2000), permeable (Cao et al., 2004), and
haemorrhagic (Cheng et al., 1997) vessels such as those that
are found in the process of tumor angiogenesis (Oka et al.,
2007). Controlled and sustained release of VEGF may help
to regulate the delivery rate of VEGF and circumvent these
problems by creating mature, more durable and stable vessels
(Chen et al., 2007; Ehrbar et al., 2008; Le et al., 2009; Formiga
et al., 2010). However, it is challenging to fabricate systems
that bind and deliver VEGF in a controlled manner because
most process developed to date are time-consuming, multi-
step and expensive processes. In general, translation of the
exogenous use of VEGF into the clinic is difficult (Ferrara
and Alitalo, 1999). Thus, exploring alternatives to VEGF
is crucial for ensuring rapid and safe neovascularization in
TE constructs.
Thymidine phosphorylase (TP), an enzyme which catalyzes
the reaction of thymidine into thymine, has been identified as
platelet-derived EC growth factor (PD-ECGF) (Friedkin and
Roberts, 1954; Furukawa et al., 1992). Although its molecular
mechanism is still unclear, the enzymatic activity of TP has
previously been reported to be angiogenic in vivo (Ishikawa
et al., 1989; Miyadera et al., 1995; Moghaddam et al., 1995).
Therefore, TP-dependant angiogenesis studies focus on 2-deoxy-
D-ribose (2dDR), one of the degradation products of thymidine.
2dDR has previously demonstrated to have chemotactic and
angiogenic activity in vivo (Haraguchi et al., 1994; Matsushita
et al., 1999). Similarly, our group recently demonstrated the
angiogenic potential of 2-deoxy-D-ribose (2dDR) using an ex-ovo
CAM assay (Dikici et al., 2019b) and a diabetic rat model (Azam
et al., 2019). Several groups evaluated the angiogenic activity of
2dDR in vitro but only using a narrow range of concentrations.
Thus, the dose-dependent response of 2dDR still needs to be
investigated in vitro.
Angiogenesis models are important tools to study the
angiogenic activity of agents, biomechanical stimulus and cells
(Staton et al., 2009). Current angiogenesis assays can be divided
into three categories: in vitro assays which focus on evaluating
proliferation, migration, and tube formation capabilities of
ECs, ex vivo assays such as rat aortic ring assay, chick
aortic arch assay, animal retina model, and in vivo assays
which are chick chorioallantoic membrane (CAM), zebrafish,
corneal angiogenesis, xenograft, and Matrigel R© plug assays
(Stryker et al., 2019).
Although in vivo assays are the most representative and
reliable models for the evaluation of angiogenesis, they are also
expensive, technically difficult, time-consuming, and ethically
questionable (Staton et al., 2004). On the other hand, in vitro
angiogenesis assays are inexpensive, quick, technically simple,
and reproducible, but they are usually based on evaluating only
one aspect of angiogenesis (for example, proliferation, migration,
or differentiation), and they may produce false results due to
the non-specific reaction of cells (Bahramsoltani et al., 2009).
Moreover, most of the in vitro angiogenesis assays are limited to
static, two-dimensional (2D) cell culture systems where culturing
cells on stiff and flat substrates is a simplified method and
does not represent the dynamic and highly complex tissue
systems (Hutmacher, 2010; Ravi et al., 2015). 2D culture of cells
distorts cell-cell and cell-matrix interactions which affects cell
proliferation, migration and differentiation (Cukierman et al.,
2001; Pampaloni et al., 2007), whereas 3D in vitro models better
represent the in vivo situation in a cost-effective way and with no
ethical concerns (Ravi et al., 2015). To date, none of the studies
demonstrated an in vitro model which allows researchers to
evaluate angiogenesis assessing both proliferation and migration
of ECs in a 3D dynamic environment.
In this study, we evaluated the angiogenic potential of 2dDR
using established in vitro angiogenesis assays, and we assessed the
potential of the newly developed tubular 3D dynamic model to be
used in the evaluation of two phases of angiogenesis together; cell
proliferation and migration in a dynamic environment. The 3D
system was designed in a bilayer tubular design. The nanofibrous
structure of the inner tube mimics the basement membrane
and provides a suitable environment for EC attachment and
formation of an endothelial monolayer whereas the highly
porous and interconnected outer polymerised high internal phase
emulsion (PolyHIPE) tube enables cell infiltration and migration
through the pores.
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MATERIALS
Pentaerythritol (98%), ε-caprolactone, tin (II) 2-ethylhexanoate,
triethylamine (TEA), methacrylic anhydride (MAAn),
photoinitiator (PI) (2,4,6-Trimethylbenzoyl Phosphine
Oxide/2-Hydroxy-2-Methylpropiophenone blend), trypsin,
paraformaldehyde (PFA), resazurin sodium salt, ethanol,
hematoxylin solution, eosin Y solution, trypan blue, Triton
X-100, Polydimethylsiloxane (PDMS, silicone), vascular
endothelial growth factor (human), 2-deoxy-D-ribose (2dDR),
glutaraldehyde (GA), goat serum, fetal calf serum (FCS) and
crystal violet were purchased from Sigma Aldrich (St. Louis,
Missouri, USA). Chloroform, industrial methylated spirit
(IMS), toluene, dichloromethane (DCM) and methanol were
purchased from Fisher Scientific (Pittsburgh, PA, USA). The
surfactant Hypermer B246-SO-M was received as a sample from
Croda (Goole, UK). 4′,6-diamidino-2-phenylindole (DAPI)
solution and Alexa Fluor 594 Phalloidin were purchased from
ThermoFisher Scientific (San Jose, CA, USA). Optimum cutting
temperature tissue freezing medium (OCT-TFM) was purchased
from Leica Biosystems (Newcastle, UK). Collagenase A was
purchased from Roche (Indianapolis, IN, USA). Human Aortic
Endothelial Cells (HAECs) and EC Growth Medium (EC GM)
were purchased from PromoCell (Heidelberg, Germany). Poly3-
hydroxybutyrate-co-3-hydroxyvalerate (PHBV) was purchased
from Goodfellow (London,UK). Alexa Fluor R© 594 anti-human
CD31 Antibody was purchased from Biolegend (San Diego, CA,
USA). Cell culture inserts and Matrigel R© were purchased from
Corning (New York, NY, USA).
METHODS
Assessment of the Angiogenic Potential of
2dDR Using Established in vitro Assays
Human Aortic Endothelial Cell (HAEC) Culture
HAECs removed from liquid nitrogen were immediately thawed
at 37◦C and transferred to a container with 10mL of EC growth
medium (GM). Cells were centrifuged at 1,000 rpm for 5min, and
the cell pellet was re-suspended in EC GM supplemented with a
total of 5% fetal calf serum (FCS) and growth medium two kit
supplements. The cell suspension was then transferred into 75
cm2 flasks and incubated at 37◦C, 5% CO2 (Thermo Scientific,
Massachusetts, USA). The culture media was replaced every 3
days until they reached ∼80–90% confluency. HAECs were used
between passages two and six.
Preparation of Pro-angiogenic Agents
Working solutions of all substances were prepared fresh at the
beginning of each experiment. 10mM 2dDR stock solution was
prepared by dissolving in low serum (2% FCS) EC GM and
filtered using a 0.2µm syringe filter. 1, 10, 100µM, and 1mM
concentrations of 2dDR were prepared by diluting the 10mM
2dDR stock solution in low serum EC GM. 80 ng/mL VEGF
solution was prepared in EC GM and used as a positive control.
VEGF will be used to describe VEGF 80 ng/mL throughout the
paper unless otherwise stated. Low serum EC GM was used as a
control in the experiments.
Evaluating the Effect of 2dDR on the Proliferation of
HAECs
Alamar blue metabolic activity assay
Alamar Blue Cell Viability Assay was performed to evaluate the
effect of different concentrations of 2dDR on HAECs growth
in vitro. The principle of this assay is the reduction of non-
fluorescent resazurin to highly fluorescent resorufin by the
metabolically active cells.
Once the HAECs reached ∼80–90% confluency, they were
trypsinized and seeded into 48-well plates with a seeding density
of 1 × 104 HAECs/cm−1. Alamar Blue Cell Viability Assay was
performed at days 1, 4, and 7. Briefly, 1mM of Alamar Blue
stock solution was prepared by dissolving 0.025 g of resazurin
sodium salt in 100ml of deionised water and filter sterilized.
0.1mM Alamar Blue working solution was prepared by 10×
dilution of the 1mM sterile Alamar Blue stock solution with
EC GM. Growth medium was removed, and the cells were
washed with PBS. One milliliter of Alamar Blue working solution
was added to each well and incubated at 37◦C for 4 h. After
an incubation period of 4 h, 200 µL of the solution was
transferred into 96-well plate, and the fluorescence readings were
done at the excitation wavelength of 540 nm and an emission
wavelength of 635 nm.
Fluorescent staining of cell nuclei and cytoskeleton
In order to visualize the cells after 7 days, fluorescent staining
was performed by labeling F-actin and cell nuclei of HAECs. Cells
were washed with PBS before (once) and after (three times) fixing
them in 4% PFA for 15min. 0.1% (v/v) Triton 100× (in PBS)
was added on samples, and the samples were incubated for 20–
30min at room temperature (RT). After three times washing with
PBS, Alexa Fluor 594 Phalloidin (1:40 diluted in PBS from stock
solution) solution was added to cells in order to stain F-actin
filaments of cells and incubated for 30min at RT in the dark. Cells
were then washed three times with PBS. Nuclei were stained with
DAPI solution (1:1,000 diluted in PBS), which strongly binds the
adenine-thymine rich regions of DNA. The DAPI solution was
added to cells and incubated for 10–15min at RT in the dark,
and cells were then washed three times with PBS. Cells were
then examined with a fluorescent microscope (Nikon Eclipse Ti,
Tokyo, Japan).
CD31 staining
CD31 immunofluorescent staining was performed to evaluate
the expression of CD31 of HAECs treated with different
concentrations of 2dDR and VEGF. At day 7, cells were fixed
with 4% PFA and washed with PBS. Cells were incubated with 5%
goat serum to avoid non-specific binding. Alexa Fluor R© 594 anti-
human CD31 Antibody staining solution was prepared by the
dilution of 1:50 in 5% goat serum. Cells were incubated with the
antibody staining solution overnight at 4◦C. HAECs were finally
counterstained with DAPI (1:1,000 diluted in PBS) as described
in section Fluorescent Staining of Cell Nuclei and Cytoskeleton
after washing three times with PBS. CD31 expression was
visualized under a fluorescent microscope after washing the
cells with PBS.
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Evaluating the Effect of 2dDR on Stimulating the
Migratory Response of HAECs Using a Modified
Boyden Chamber Migration Assay
The Boyden chamber assay was developed for analyzing
leukocyte chemotaxis in the 1960s (Boyden, 1962). There are
two compartments containing media, and these compartments
are separated with a microporous membrane. Cells are seeded
into the top compartment (a cell culture insert) while the
chemoattractant is placed into the compartment below (well
plate). Herein, we used a modified Boyden chamber assay
to evaluate the migratory response of HAECs to 2dDR in
comparison with VEGF.
Briefly, 800 µL of chemoattractant solutions and low serum
EC GM (as control) were added to the 24-well plates (lower
chamber), and 8µm pore size cell culture inserts were placed
onto the solutions carefully by avoiding bubble formation.
HAECs were trypsinized, centrifuged, and 5 × 104 HAECs
resuspended in 300 µL of low serum EC GM were seeded
into the cell culture inserts (upper chamber). After incubation
for 4 h at 37◦C, cells which were not migrated were removed
from the upper surface of the cell culture insert by scraping
with a cotton bud. Cell culture inserts were fixed with 4% PFA
for 10min, and the migrated HAECs were stained with 0.1%
crystal violet (wt/vol in deionised water) solution for 10min
before washing three times with deionised water. Bright-field
images were taken with the fluorescent microscope, and the
migration was quantified with a multi-step image processing of
the green channel images exported from microscope software
(NIS-Elements, Tokyo, Japan).
Briefly, the green channel images were converted to binary
images with ImageJ (Wayne Rasband, National Institutes of
Health, USA), and the black pixels which are the cells) were
counted from the histograms. Four areas of interest were chosen
randomly from each image, and the mean number of migrated
cells was taken for each group.
Evaluating the Effect of 2dDR on Tube Formation of
HAECs Using Matrigel® Tube Formation Assay
In vivo, ECs are in direct contact with a basement membrane
which is specific and biologically functional for enabling ECs
to form tube structures (Kalluri, 2003). Matrigel R© is the
trade name of a gelatinous protein mixture produced from a
hamster fibrosarcoma, which is rich in collagen IV, laminin,
proteoglycans and growth factors. This biologically active protein
mixture is used as an in vitro substitute for mimicking native
basement membrane of ECs and promotes ECs to form tube-
like capillary structures (Kleinman and Martin, 2005). The tube
formation assay is widely used as a bioassay for one aspect of
neovascularization in vitro.
We examined whether 2dDR stimulates the tube formation
of HAECs using the Matrigel R© tube formation assay. Briefly,
working on the ice, 48-well plates were thickly coated with
growth factor reducedMatrigel R© by adding 120µL of Matrigel R©
into each well. The plates were incubated at 37◦C for 60min to
allow solidification of the Matrigel R©. HAECs were trypsinized,
centrifuged, and seeded on Matrigel R©-coated plates at a density
of 2.5 × 104 cells/well and treated with 100µM of 2dDR in
comparison with VEGF and a non-supplemented control of
EC GM. HAECs were incubated at 37◦C for 18 h before fixing
them in 2% PFA solution containing 0.1% GA for 15min. Tube
formation was quantified using Angiogenesis Analyzer plugin of
ImageJ (Brown et al., 2016).
Design, Manufacturing, and
Characterization of the 3D Dynamic Model
The 3D system was designed to be two-layers; the inner
tube of nanofibers to serve as a suitable environment for
HAECs to attach, proliferate and form a monolayer to represent
an endothelium, and the outer tube of the highly porous
and interconnected environment to enable proliferation and
migration of HAECs from the formed endothelial monolayer.
3D bilayer tubes used in this study were manufactured
combining two manufacturing methods; emulsion templating
and electrospinning, and they were characterized using scanning
electron microscopy.
Manufacturing of the Outer Tube by Emulsion
Templating
Synthesis of polycaprolactone (PCL) methacrylate
The PCL used in this study is 4-arm PCL methacrylate
(4PCLMA) which we have previously reported the detailed
synthesis (Aldemir Dikici et al., 2019b). Throughout the paper,
the term ‘PCL polymerised high internal phase emulsion
(PolyHIPE)’ will be used to describe 4PCLMA PolyHIPE, unless
otherwise stated.
Briefly, pentaerythritol (12 g, 0.088mol) and ε-caprolactone
(80.49 g, 0.353mol) were mixed in a round flask at 160◦C while
stirring continuously at 200 rpm. When pentaerythritol was
dissolved, tin (II) 2- ethylhexanoate (as a catalyst) was added,
and the system was left for reaction overnight with stirring.
Then, stirring was stopped, and the system was removed from
the oil bath to cool down in the ambient atmosphere. Hydroxyl-
terminated 4-arm PCL was obtained, and to methacrylate
functionalise, it was dissolved in 300mL of DCM, and then TEA
(52.65 g, 0.52mol) was added. The flask was placed in an ice bath.
MAAn (80.22 g, 0.52mol) was dissolved in 100mL DCM and
transferred into a dropping funnel. When the addition of MAAn
was completed, the ice bath was removed, and the system was
kept at RT overnight with stirring at 375 rpm. To remove the
TEA, MAAn and the salts formed, the methacrylated PCL was
washed three times with HCl solution (1M, 1,000mL), separated
using a separating funnel, and then washed three times with
pure deionised water. Almost all solvent was evaporated using
a rotary evaporator. PCL was then dissolved in methanol, then
precipitated out of methanol by placing in −80◦C freezer. Three
methanol washes were used, and any remaining solvent was
removed by using the rotary evaporator. 4PCLMA was stored in
an appropriate vessel in the freezer (−20◦C) for further use.
Preparation of PCL HIPEs
4PCLMA (0.4 g) and the surfactant Hypermer (10% w/w of
polymer) were added into a glass vial and heated to 40◦C to
dissolve surfactant. Solvent blend [150% w/w of polymer, 80%
chloroform, 20% toluene (w/w)] and PI (10% w/w of polymer)
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FIGURE 1 | Manufacturing route of the polymeric bilayer tubes (A) Developed molding system to manufacture PCL PolyHIPE tubes, (B) electrospinning setup for
manufacturing of PHBV electrospun tubes, (C) assembling PCL PolyHIPE and PHBV electrospun tubes to create bilayer tubes, and (D) macroscopic view of the
bilayer tube.
were added in 4PCLMA-surfactant mixture, respectively, and
mixed at 375 rpm using a magnetic stirrer for 1min at RT. Once
the homogeneous mixture formed, 2.5mL of water (internal
phase volume 80% v/v) was added dropwise in 3min and the
emulsion was mixed further 30 s more.
The polymerization of PCL HIPEs
A mold made of silicone tubes, stoppers, and a copper rod was
assembled (Figure 1A). PCL HIPE was injected into the mold by
using a syringe and polymerised for 3min on both sides using a
UV curer with a 100W.cm−2 UV bulb (Omnicure Series 1000,
Lumen Dynamics, Canada).
The resulting parts were recovered, soaked in 100%
methanol for 24 h with four changes to remove any remaining
contaminants of surfactant, solvent or uncured material. Then
the samples were left in methanol [50% (v/v) in water] for 24 h
and then in water for a further 24 h. Finally, the samples were
taken out from the water and left in the freezer (−80◦C) for
an hour then transferred into a vacuum oven and left for a
day to preserve the porous structure of PCL PolyHIPE without
any collapse.
Manufacturing of the Inner Tube by Electrospinning
Poly3-hydroxybutyrate-co-3-hydroxyvalerate (PHBV) [10%
(w/w)] pellets were dissolved in DCM:methanol (90:10 w/w)
solvent blend, and the solution (∼5mL) was loaded into 5mL
syringes fitted with 0.6mm inner diameter blunt syringe tips.
The syringe was then placed in a syringe pump (GenieTMPlus,
KentScientific, Connecticut, USA). L-Shape T9 Torx key
(∼2.5mm diameter) (purchased from a local supplier) was used
as the mandrel and placed at a distance of 17 cm from the needle
tip (Figure 1B). The rotator and the pump were set to 250 rpm
and 40 µL/min, respectively. A 17-kV voltage was applied to
both the collector and the tips. The solution was then electrospun
at RT for 10 min.
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Air Plasma Treatment to Improve Cell Attachment
After fabrication of the inner and outer tubes, both tubes
were treated with air plasma (Diener Electronic, Ebhausen,
Germany) with a power of 50W and a pressure of 0.8
mbar for 60 s to improve cell attachment to the hydrophobic
surfaces as demonstrated in our previous work (Figure 1D)
(Aldemir Dikici et al., 2019a).
Assembling of PCL PolyHIPE and PHBV Electrospun
Tubes
PCL PolyHIPE tube was soaked in ethanol, removed and the
excess alcohol was shaken off. Without letting it dry, the PHBV
electrospun tube was inserted into PCL PolyHIPE tube, and
they were soaked in ethanol and gradually transferred into
70% ethanol for sterilization and then transferred into PBS
for complete integration of two layers which occurred due
to the shrinkage of PCL PolyHIPE layer. Then 80 holes per
tube were pierced using 23G syringe needles as escape holes
as described previously (Dew et al., 2016) for enabling the
migration of the ECs from the inner PHBV tube to the outer PCL
PolyHIPE layer.
Scanning Electron Microscopy
Micro-architectures of PCL PolyHIPE, PHBV electrospun, and
the bilayer tubes were examined using a scanning electron
microscope (SEM). All samples were gold-coated with a voltage
of 15 kV for 2.5min using a gold sputter coater (Edwards
sputter coater S150B, Crawley, UK) to increase conductivity.
SEM (Philips/FEI XL-20 SEM; Cambridge, UK) was used with
10 kV power.
Design and Manufacturing of the Chamber
A chamber with a lid was manufactured using 3D printing
technique to serve as a reservoir for culture media and
to enable the connection of the 3D bilayer tubes to
lateral flow.
The 3D models of the chamber and the lid were designed
using Autodesk Inventor Professional 2020 (San Rafael, CA,
USA). The chamber had inner dimensions of 70 × 25 × 25mm
with 2mm material thickness and with input and output holes
which have an inner diameter of 3mm. The lid had 75 ×
30 × 5mm inner dimensions with 2mm material thickness.
The model was then saved as a standard tessellation language
(STL) file. The STL file was imported into Formlabs Form 2
printer (Somerville, MA, USA) and printed using the resin;
Dental LT Clear (Figure 2A). Following this, the chamber and
lid were washed with isopropanol, post-cured at 60◦C for 1 h
and washed with ethanol. Then the chambers were air-dried,
and silicone tubes were sealed into the input and output holes
of the chambers (Figure 2B). Chamber systems were sterilized
using 70% (v/v) ethanol solution (in deionised water). Briefly,
they were soaked in the ethanol solution in the laminar hood
and left for 2 h, air-dried in the hood for 1 h and washed with
PBS three times for 2 h. The connectors and the silicone tubing
were sterilized by using an autoclave, and the whole system
was assembled in a laminar hood under sterile conditions using
sterile forceps.
Testing the Diffusion Pattern Between the
Tube and the Chamber
The bilayer tube was connected to the chamber, and the chamber
was filled with 30mL of deionised water. Trypan blue was
injected into the silicone tube to be circulated, and 10 dyn/cm2
flow was applied to the system.Macroscopic images of the system
were captured at the end of 1, 5, and 10min to observe the
diffusion of the trypan blue. At the end of the experiment,
deionised water in the chamber was collected, and the volume
was measured.
Assessment of the Angiogenic Potential of
2dDR Using a Newly Developed 3D
Dynamic Model
Rotational Cell Seeding Into Bilayer Tubes
One end of the tubes was occluded, as shown in Figure 2C and
bilayer tubes were left in 70% ethanol for 2 h and then washed
with PBS three times in sterile conditions. Finally, they were
conditioned with media for an hour in the incubator in 24-well
plates. HAECs were trypsinized, counted, and centrifuged. The
cell pellet was re-suspended in fresh media, and 106 cells/300 µL
were injected into tubes using a syringe, as shown in Figure 2D.
Once all the cell suspension was injected, the other end was
closed using a cap (Figure 2E). Tubes were transferred in a 15mL
centrifuge tube with 10mL EC GM and placed in a cylindrical
rotator turning at 1 rpm in a 37◦C, 5% CO2 humidified incubator
for 4 h for the attachment of HAECs.
3D Culture of HAECs in the Newly Developed
Dynamic Model for the Assessment of Angiogenesis
Following cell seeding, caps in both ends of the bilayer tubes
were removed, and bilayer tubes were connected to silicone
tubing in the printed chamber using sterile forceps (Figure 2F).
HAECs in bilayer tubes were cultured for a week. In 3D
experiments, the individual effect of flow, pro-angiogenic agents
and their combined effect on EC infiltration were investigated.
Flow experimental groups were static (control), 1, 2, and 10
dyn/cm2. Then, drug experimental groups; 100µM 2dDR and
VEGF were investigated under static conditions. Finally, 100µM
2dDR and VEGF were further investigated under 2 dyn/cm2 flow
and compared with the static conditions.
Hematoxylin and Eosin (H&E) Staining
Bilayer tubes cultured with HAECs for a week were stained with
H&E using a standard protocol (Fischer et al., 2008). Briefly,
samples were washed with PBS and fixed with 3.7% FA. They
were washed with PBS, and excess water was removed using
filter paper. Meanwhile, cryomoulds were filled with OCT-TFM.
Samples were embedded into it, and the rest of the volume was
then filled with OCT-TFM to the top. Cryomoulds were placed
into −80◦C freezer and incubated for 30min until solidified.
Frozen blocks were fixed on mounting platforms, and placed
into a cryostat (Leica CM1860 UV, Milton Keynes, UK) before
sections were sliced at 8µm and immediately mounted onto the
surface of Thermo SuperFrost R© Plus slides. For H&E staining,
slides were stained with hematoxylin for 90 s and eosin for 5min
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FIGURE 2 | Route followed starting from the chamber manufacturing to the implementation of the tubes to the fabricated chamber. (A) Manufactured chamber using
3D printing, (B) implementation of the tubing to the chamber, (C) preparation of the tubes for seeding, (D) administration of the cell suspension into tubes using a
syringe, (E) closing the other end with a cap to prevent leakage of the cell suspension from the tube upon seeding, and (F) implementation of the cellularized tube to
the chamber.
and they were dehydrated, cleared and mounted the slide using
the permanent mounting medium.
Fluorescent Staining
Bilayer tubes were fixed with 4% PFA for 30min and washed
gently with PBS prior to submerging into 0.1% (v/v) Triton X
100 (in PBS) solution for 20min and stained as described in
section Fluorescent Staining of Cell Nuclei and Cytoskeleton.
Then, the stained tubes were sectioned, as explained in section
Hematoxylin and Eosin (H&E) Staining and imaged under a
fluorescent microscope (Olympus IX3, Tokyo, Japan).
Statistical Analysis
Statistical analysis was carried out using one-way and two-way
analysis of variance (ANOVA) using statistical analysis software
(GraphPad Prism, CA, USA). Where relevant, n values are given
in figure captions. Error bars indicate standard deviations in the
graphs unless otherwise stated.
RESULTS
Evaluation of the Angiogenic Potential of
2dDR Using Established in vitro Assays
2dDR Improves the Metabolic Activity and
Proliferation of HAECs in a Dose-Dependent Manner
The results of metabolic activity assays showed that 80 ng/ml of
VEGF increased metabolic activities and the total number of cells
as expected. The effect of VEGF was evident even at day 1 (but
not statistically significant) but clearly significant by days 4 and
7. By day 7, cell number essentially doubled by the addition of
VEGF (Figure 3). At 100µM, 2dDR was as effective as VEGF
in stimulating metabolic activity and cell number without any
adverse effect on the appearance of cells. Lower concentrations of
2dDR were found less effective. At higher concentrations, 1mM
2dDR was slightly less effective when compared with 100µM,
and at 10mM concentration cells detached from the culture wells
by day 4.
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FIGURE 3 | (Top graph) The metabolic activities of HAECs over 7 days and (bottom graph) the normalized number of HAECs at the end of day 7. DAPI/Phalloidin
staining and CD31 expressions of HAECs at the end of day 7 when treated with different concentrations of 2dDR in comparison with VEGF and controls [***p ≤
0.001, **p ≤ 0.01, *p ≤ 0.05, not significant (ns) p ≥ 0.05, n = 3]. Scale bars represent 200µm.
The results of the fluorescent staining at day 7 showed that
cell proliferation was correlated with the metabolic activities
of HAECs. The quantification of the fluorescent images
demonstrated that when cells were treated with VEGF for 7
days, the number of cells was increased approximately 2.2-fold
in comparison with the controls. Similarly, 100µM 2dDR almost
doubled the cell number at the end of day 7. No statistical
difference was observed for other concentrations of 2dDR apart
from 10mM. HAECs detached from the surface of the well plate
when cells were treated with 10mM of 2dDR for 4 or 7 days.
The treatment of HAECs with VEGF and 2dDR did not
affect CD31 expression of HAECs. All groups apart from 10mM
of 2dDR showed similar levels of expression of CD31, which
were correlated with the number of cells at the end of day
7. No expression of CD31 was observed for 10mM 2dDR
groups, as all cells had detached. Accordingly, for the following
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FIGURE 4 | The migratory effect of different concentrations of 2dDR in comparison with VEGF and controls was evaluated by using a modified Boyden chamber assay.
The quantified results were given in the graph bottom-right [****p ≤ 0.0001, **p ≤ 0.01, *p ≤ 0.05, not significant (ns) p ≥ 0.05, n = 3]. Scale bars represent 250µm.
migration experiments, 1µM and 10mM 2dDR concentrations
were excluded as 1µM was too low to be effective and 10mM
detached cells after exposure for several days.
2dDR Enhances the Chemotactic Migration of HAECs
All three concentrations of 2dDR (10, 100µM, and 1mM)
and VEGF significantly enhanced the chemotactic migrations
compared with the control group (Figure 4). Quantification of
the results indicated that the increase in the number of migrated
cells was significantly different for 100µM in comparison with
the other two concentrations of 2dDR. The addition of VEGF
significantly increased the number of migrated HAECs when
compared with 100µM2dDR, which was also selected for further
tube formation experiments.
2dDR Improves the Ability of HAECs to Form
Tube-Like Structures
The administration of 2dDR and VEGF significantly improved
the ability of HEACs to form tubes in Matrigel R©, whereas cells
were partly capable of forming these structures in the control
group (Figure 5). The results indicated that the inclusion of
2dDR and VEGF significantly increased the number of branch
points to 86 ± 7 and 100 ± 13, respectively from controls
(average number of branch points: 38 ± 10). Similarly, the
number of tubes per field was increased 1.8- and 2.3-fold with the
administration of 2dDR and VEGF, respectively, when compared
with control.
Design, Manufacturing, and
Characterization of the Developed 3D
Dynamic System
The 3D bilayer tubes, Figures 6A–C, which consists of an inner
PHBV electrospun tube for ECs to attach and form an endothelial
monolayer and an outer PCL PolyHIPE tube which provides
a highly porous and interconnected environment for ECs to
infiltrate was developed successfully following the manufacturing
route illustrated in Figure 1.
The surface morphology of PHBV electrospun was beadless
with random (non-aligned fibers) fiber orientation where the
average fibers and pore sizes were 0.70 ± 0.25 and 3.64
± 2.16µm, respectively (Figure 6D). The outer layer, PCL
PolyHIPE, had an average pore size of 30± 13µm (Figure 6E).
The 3D culture chamber manufactured using 3D printing
was capable of supporting the culture of HAEC in bilayer tube
for periods of 7 days. There was no leakage or contamination
throughout the experiments. The resin, Dental LT Clear, used for
manufacturing of the chamber was reported to be biocompatible
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FIGURE 5 | The effect of 100µM 2dDR and VEGF on tube formation was assessed with Matrigel® tube formation assay. The quantified results of the average number
of branch points and the number of tubes per field were given in the graphs given [****p ≤ 0.0001, **p ≤ 0.01, *p ≤ 0.05, not significant (ns) p ≥ 0.05, n = 3]. Scale
bars represent 250µm.
FIGURE 6 | (A,B) SEM image of the cross-section of the bilayer tube, (C) Macroscopic image of the bilayer tube, (D) SEM images of the of PHBV electrospun, and
(E) PCL PolyHIPE.
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by the manufacturer. It was resilient to 70% ethanol for
sterilization of the chamber. Its transparency was advantageous
for bioreactor chambers to be able to allow the visual inspection
of themedia color without opening the lid, which reduces the risk
of contamination throughout the culture. This petri-dish inspired
design is reproducible, cost-effective ($15/chamber) and allows
gas exchange. Its small dimensions enable multiple chambers to
be used in the same incubator at the same time.
Assessment of the Angiogenic Potential of
2dDR Using Newly Developed 3D Dynamic
Model
Flow Mediates Proliferation and Outgrowth of ECs:
Low Shear Stress Promotes Proliferation and
Migration of HAECs
HAECs were seeded in bilayer tubes and cultured under static,
1 dyn/cm2 flow, and 2dyn/cm2 flow formed a continuous
endothelial monolayer at the end of a 1-week culture period
(Figure 7). The cells cultured in tubes under 10 dyn/cm2 flow
showed relatively poor cell distribution, which is likely due to
cells were washed out because of the comparably high flow
rate which gave the lowest cell density observed amongst all of
the groups. However, migration of HAECs through electrospun
fibers was higher under 10 dyn/cm2 shear stress (202.6 ±
107.7µm) compared with the static group where no outgrowth
was observed. HAEC outgrowth and cell density in tubes cultured
under 2 dyn/cm2 flow were significantly higher and statistically
different than other groups. HAECs migrated approximately
533 ± 90.8µm in 7 days under 2 dyn/cm2 shear stress while
the outgrowth was 231.5 ± 70.1µm when 1 dyn/cm2 shear
applied. Moreover, at day 7, the normalized density of cells in
the tubes was significantly increased under 2 dyn/cm2, and it was
approximately 2-, 1.4-, and 12-fold higher in comparison with
static, 1, and 10 dyn/cm2 shear stress conditions, respectively.
Fluorescent and H&E staining of the HAECs under static and
flow conditions are given in Figure 7.
Testing the Diffusion Pattern Between the Tube and
the Chamber
To test the diffusion behavior between the chamber and the tube
visually, the trypan blue dye was circulated in the system, and
macroscopic images of the chamber were captured at 1, 5, and
10min (Figure 8A). Images showed the gradual release of the
dye from the inner tube to the chamber. Also, the volume of the
liquid in the chamber was measured both at the beginning of the
experiment and at the end of 10min of circulation, and it was
30mL at both time points.
2dDR and VEGF Promotes Proliferation and
Outgrowth of HAECs Under Static Conditions
In 2dDR and VEGF supplemented groups, HAECs in the
electrospun tube formed a dense-packed endothelial monolayer
inside the tube. NoHAEC infiltration was observed in the control
group which was not supplemented with any drug under static
conditions whereas in 2dDR and VEGF supplemented groups,
HAECs were able to migrate through PCL PolyHIPE layer
approximately 182.2 ± 81.6 and 264.9 ± 88.1µm, respectively.
There was no statistically significant difference between VEGF
and 2dDR supplemented tubes under static conditions in terms
of HAEC outgrowth. The cellular densities in the tubes under
static conditions were increased 1.2- and 1.5-fold by the addition
of 2dDR and VEGF, respectively.
Pro-angiogenic Agents (2dDR and VEGF) and Fluid
Forces Cooperate to Improve the Outgrowth and
Proliferation of HAECs
The highest distance of outgrowth and a dramatic increase in the
cellular density was observed when HAECs were exposed to the
simultaneous application of the angiogenic drugs and the flow.
HAECs cultured under 2 dyn/cm2 shear stress with a growth
medium supplemented with either 2dDR or VEGF migrated up
to 779.8± 110.3 and 797.3± 72.5µm, respectively. Furthermore,
the cellular densities in the tubes were increased 3.8- and 3.2-fold,
respectively, for 2dDR and VEGF groups under 2 dyn/cm2 shear
stress when compared with the drug including static controls.
There was no statistically significant difference observed between
2dDR and VEGF groups under 2 dyn/cm2 shear stress in terms of
HAEC outgrowth. Fluorescent and H&E staining of the HAECs
under static and flow conditions either administered with drugs
or non-treated are given in Figure 9. The graph showing the
quantified results of flow and drug experiments and the statistical
analysis is given in Figure 10.
DISCUSSION
VEGF is a crucial angiogenic factor that plays a key role in
promoting angiogenesis (Hoeben et al., 2004). ECs are sensitive
to VEGF signaling, which regulates their proliferation, migration
and survival (Olsson et al., 2006; Wang et al., 2008). Although
VEGF is commonly accepted as the gold standard for promoting
angiogenesis, the use of exogenous VEGF can promote the
formation of leaky (Yancopoulos et al., 2000), permeable (Cao
et al., 2004), and haemorrhagic (Cheng et al., 1997) vessels when
administered in an uncontrolled manner. VEGF is the most
widely studied pro-angiogenic factor, and several reports have
established the signaling pathway responsible for its angiogenic
activity (Hoeben et al., 2004; Koch et al., 2011).
2dDR is a promising pro-angiogenic alternative which has
been reported to have chemotactic and angiogenic activity by our
group and other researchers using a range of current angiogenic
assays: Boyden chamber assay (Uchimiya et al., 2002), tube
formation assay (Uchimiya et al., 2002), CAM assay (Haraguchi
et al., 1994; Dikici et al., 2019b), and rat wound healing models
(Yar et al., 2017; Azam et al., 2019). However, the dose-dependent
response to 2dDR still remains to be investigated in vitro to
determine what is the effective concentration range to drive
angiogenesis at the cellular level.
In contrast to VEGF, the mechanism of action of 2dDR
remains still unclear. Only a few studies have proposed a pathway
to explain the angiogenic mechanism behind this small sugar
molecule. Briefly, two main mechanisms have been proposed
when it comes to the angiogenic activity of 2dDR at the
molecular level. In the first proposed mechanism, researchers
suggest the endogenous production of 2dDR by enzymatic
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FIGURE 7 | Effect of flow on the outgrowth distance, cell density and the cell monolayer formation of HAECs. (Top) Phalloidin TRITC, (Bottom) H&E staining of the
sections of the bilayer tubes cultured with HAECs for a week under static culture and dynamic culture with 1, 2, and 10 dyn/cm2 flow from left to right, respectively.
degradation of thymidine to thymine promotes oxidative stress
and consecutively stimulates the secretion of angiogenic factors
such as VEGF and interleukin-8 (IL-8) which can be internalized
by ECs and promote angiogenesis (Brown et al., 2000; Sengupta
et al., 2003; Nakajima et al., 2012). In the second mechanism,
which has been recently studied by Vara et al. (2018), the 2dDR-1-
phosphate (2dDRP) is produced either internally by cells which
express TP such as macrophages, platelets and cancer cells and
then secrete this extracellularly, or TP may be released from
injured cells to act on enzymatic degradation of thymidine
and generation of 2dDR extracellularly. 2dDRP then can be
taken up by ECs, and this then activates NADPH oxidase 2
(NOX2) which later acts on nuclear factor kappa B (NF-κB).
NF-κB then upregulates the VEGF receptor 2 (VEGFR2) and
thus drives VEGF-dependent angiogenesis. Both mechanisms are
summarized in Figure 11.
As must be evident in these early days of studying 2dDR,
the clarification of the mechanism of action of 2dDR remains
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FIGURE 8 | Testing the diffusion pattern between the chamber and the bilayer tube. (A) The diffusion of trypan blue dye from flow system to the outer chamber, (B)
Schematic diagram of the system, and (C) cross-sectional view of the tube showing the dye gradient between bioreactor chamber and inside of the tube at any point
till balance point.
to be definitely established, and this is beyond the remit of this
study. In this study, we wished to learn more about the biological
activity of this sugar using a range of well-established in vitro
models and in particular to establish the effective concentration
range of this small sugar.
To test the angiogenic activity of added pro-angiogenic
factors, biomechanical stimulus and cells, angiogenesis models
are important tools (Staton et al., 2009), and the current
angiogenesis assays can be divided into three categories: in
vitro assays which focus on evaluating proliferation, migration,
and tube formation capabilities of ECs (Hayakawa et al., 2015),
ex-vivo assays and in vivo assays (Stryker et al., 2019). Although
in vivo, assays are the most representative and reliable models
for the evaluation of angiogenesis, they are also expensive,
technically difficult, time-consuming and ethically questionable.
On the other hand, in vitro angiogenesis assays are inexpensive,
quick, technically simple, and reproducible, but they are usually
based on evaluating only one aspect of angiogenesis, and as
such do not represent the complexity of angiogenesis which
occurs in vivo. A comparison of current angiogenesis assays in
terms of cost-effectivity, ethical concerns, reproducibility, the
requirement of special skills, representations of the physiological
angiogenesis and the duration of the assay are given in Table 1.
When all the drawbacks of these methods are considered,
there is a need for a 3D dynamic system which enables the study
of angiogenesis in vitro in a more physiological complex 3D
environment which includes the introduction of flow which is a
major stimulus for neovascularization in vivo.
Experiments in this study were designed with three key
objectives; (i) to assess the angiogenic activity of 2dDR using
established 2D in vitro angiogenesis assays, (ii) to develop a
3D dynamic system to be used for testing of pro-angiogenic
agents, (iii) to evaluate the efficiency of 2dDR in encouraging
proliferation and infiltration of HAEC using in vitro 3D dynamic
system to study the suitability of our model to be used as a
3D in vitro angiogenesis model. Throughout these experiments,
we used VEGF as a comparator so that we can answer how
biologically effective 2dDR is compared to this well-documented
major pro-angiogenic factor.
First, we have investigated the effect of 2dDR on proliferation,
chemotactic migration and tube formation ability of HAECs.
The results of the metabolic activity assay showed a dose-
dependent response in the metabolic activity of HAECs. It
was not effective when used at low concentrations (1µM) but
significantly improved metabolic activity and proliferation of
HAECs when used at 100µM and to a lesser extent 1mM. It
inhibited cellular proliferation at higher concentrations (10mM)
by detaching the cells. 100µM 2dDR was found ∼95% as potent
as VEGF in terms of enhancing the proliferation of HAECs over 7
days. Following the metabolic activity assay, three concentrations
of 2dDR (10, 100µM, and 1mM) were further examined for
enhancing the chemotactic migration of HAECs using a modified
Boyden chamber assay. All the 2dDR concentrations and VEGF
showed a statistical difference when compared with controls
in terms of migration of HAECs from the upper chamber to
the lower one where the chemoattractant was located. Hundred
micrometer group was then selected for further experiments
to evaluate how the addition of 2dDR and VEGF influences
the formation of capillary tube-like structures using a well-
established method of assessing angiogenesis, Matrigel R© tube
formation assay (Ponce, 2009). The administration of 100µM of
2dDR and 80 ng/ml of VEGF increased the number of capillary
tubes formed and the number of branch points.
Thus, the in vitro assessment of the angiogenic activity of
2dDR showed it to be dose-dependent reproducing all of the
actions of VEGF with 2dDR stimulating proliferation, migration
and tube formation of HAECs. Hundred micrometer of 2dDR
was essentially equivalent to 80 ng/mL of VEGF, and this was
selected for further evaluation in the newly developed 3D
dynamic angiogenesis model.
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FIGURE 9 | The combined effect of 2dDR, VEGF, and flow (2 dyn/cm2 ) on the outgrowth distance, cell density and the cell monolayer formation of HAECs. (Top)
Phalloidin TRITC, (Bottom) H&E staining of the sections of the bilayer tubes cultured with HAECs under static culture and dynamic culture with 2 dyn/cm2 flow and
with the implementation of the angiogenic agents (VEGF and 2dDR).
The 3D dynamic system was designed in a tubular form
as seen in tissue engineering vascular graft design to enable
the application of lateral flow (Nieponice et al., 2008; Kurobe
et al., 2015; Ye et al., 2015). It was designed to be two-layers
and manufactured by combining two different manufacturing
methods, electrospinning, and emulsion templating.
The inner tube was manufactured using electrospinning, and
it is made of nanofibres to serve as a suitable environment for
HAECs to attach, proliferate and form a monolayer to represent
an endothelium. Nanofibres have been shown to provide better
surface properties for ECs to adhere to and to proliferate on
than microfibers (Keun Kwon et al., 2005; Venugopal et al., 2008;
Beachley and Wen, 2010). This is likely due to the nanofibers
being structurally similar to the ECM of natural tissue with their
submicron-scale topography and highly packed morphology
(Keun Kwon et al., 2005; Gunn and Zhang, 2010). Furthermore,
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 14 January 2020 | Volume 7 | Article 451
Dikici et al. A Novel 3D Angiogenesis Model
FIGURE 10 | Quantification of the outgrowth distance (µm) and the cell density (normalized to the static alone group) of HAECs to show the effect of flow and drugs
either in isolation or combined [****p ≤ 0.0001, **p ≤ 0.01, *p ≤ 0.05, not significant (ns) p ≥ 0.05, n = 3].
nanofibres made of PHBV have previously been shown to be a
suitable environment for ECs to form an endothelial monolayer
(Dew et al., 2016). Although nanofibres are favorable for the
formation of the endothelium layer, these close-packed fibers act
as a barrier to cell infiltration (Aldemir Dikici et al., 2019a).
In contrast, the outer tube was designed to serve as
a suitable environment for cell infiltration. An emulsion
templating method was used for the manufacturing of the
outer layer as it enables fabrication of the scaffolds with high
interconnectivity and up to 99% porosity. We have recently
reported the manufacturing route of PCL based PolyHIPEs,
and we have also shown the biocompatibility, and structural
suitability of these scaffolds in terms of cell infiltration
(Aldemir Dikici et al., 2019a,b).
Molding was used for the fabrication of the PolyHIPE tubes.
The manufacturing route of PolyHIPE tubes using 3D laser
patterning has previously been reported (Johnson et al., 2013).
However, the production of PolyHIPE based 3D structures needs
bespoke stereolithography set-ups and careful optimisation of
the printing ink, the print speed of the stage and irradiation
intensity, to produce good quality prints with PolyHIPEs. Thus,
the use of molds is a practical and convenient method to fabricate
PolyHIPEs with uncomplicated designs.
Following the fabrication of the individual layers separately,
we combined them by taking advantage of the high swelling
degree of PolyHIPEs in organic solvents (Busby et al., 2001).
The outer diameter of the PHBV electrospun tube and the
inner diameter of the PCL PolyHIPE tube were designed to
be 2.4mm when they were soaked in water or culture media.
When the PCL PolyHIPE tube was transferred from water to
ethanol, the diameter increased by more than 10% and enabled
the insertion of the PHBV tube into the PolyHIPE tube. Then,
the bilayer tube was transferred into the water, and a shrink-fit
connection between the two layers was obtained (Figures 6A–C).
After combining PHBV electrospun and PCL PolyHIPE tubes,
they maintained their structural integrity, and no delamination
was observed at any stage of the experiments over 7 days.
3D experiments were conducted to investigate the effect of (i)
flow, (ii) angiogenic agents, and (iii) their combined effect on
cellular density and the outgrowth distance of HAEC from the
inner tube to PCL PolyHIPE layer. The inner diameter of the 3D
tube was 2.4mm to partially represent the diameter of big blood
vessels such as arteries or veins, and accordingly, the shear rates
used in this study ranged between 1 and 10 dyn/cm2 to mimic
the physiological shear rates observed in some arteries and veins
(Wasserman and Topper, 2004; Chatterjee, 2018).
The results of the 3D flow experiments showed that static
culture and lower shear stresses (1 dyn/cm2 and 2 dyn/cm2)
enabled the formation of a continuous endothelial monolayer,
but the application of higher stress (10 dyn/cm2) resulted in
a discrete monolayer of HAECs. This is possibly due to the
cells being washed out at the high rate of flow. Similarly,
Kitagawa et al. demonstrated a rapid decrease in the number
of cells attached to their tubular scaffolds due to the high
flow shear stress (Kitagawa et al., 2006). Low shear stress
promoted the outgrowth of HAECs for over 7 days. 2 dyn/cm2
shear stress significantly increased the outgrowth distance of
HAECs and normalized cell density when compared with 1
and 10 dyn/cm2, whereas no outgrowth was observed under
static culture conditions. Our findings of the effect of flow
experiment on ECs are consistent with the literature (Mohan
et al., 1997, 1999). ECs are mechanosensitive, and they have
been reported to show phenotypic and functional changes
based on various flow patterns (Chistiakov et al., 2017). Shear
stress caused by laminar flow has been reported to reduce the
apoptosis while increasing the VEGF expression (dela Paz et al.,
2012) and demonstrated to regulate EC migration (Simmers
et al., 2007). Barron et al. reported a higher EC number and
infiltration under flow conditions compared to static culture
(Barron et al., 2012). Similarly, Sprague et al. demonstrated
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FIGURE 11 | Proposed pathways for VEGF and 2dDR to promote angiogenesis. (1) endogenous generation of 2dDR stimulates the production of angiogenic factors
via stimulation of oxidative stress. (2) 2dDRP takes a role in the upregulation of VEGFR2 via generation of ROS and NF-κB.
that the migration of HAECs onto a prosthetic material was
positively influenced by shear stress (Sprague et al., 1997). Urbich
et al. showed that the application of shear stress stimulates
migration of human umbilical vein ECs in a flow rate dependent
manner being at least as effective as VEGF (Urbich et al.,
2002). Mohan et al. reported increased angiogenesis-related
nuclear factor-kB (NF-κB) activity when HAECs were exposed
to low shear in comparison with high shear stress conditions
(Mohan et al., 1997).
Under static conditions, administration of 2dDR and VEGF
stimulated EC outgrowth and cell density when compared with
the static control group (no agents administered). However,
the most dramatic increase in outgrowth distance and cell
density was observed when the pro-angiogenic agents (2dDR and
VEGF) were administered under 2 dyn/cm2 shear conditions.
The outgrowth distance and cell density of HAECs under
flow conditions and when treated with VEGF and 2dDR were
significantly higher when compared to that observed when VEGF
and 2dDR were administered under static conditions. Similarly,
Song et al. reported that VEGF and fluid forces cooperate to
improve endothelial invasion into collagen gel matrix (Song
and Munn, 2011). Studying EC outgrowth is particularly
important because the formation of new blood vessels involves
budding of ECs from established vasculature toward an area
of hypoxia and increased the release of pro-angiogenic factors
such as VEGF.
Alongside the mechanotactic stimulus, the chemotactic
stimulus is the other factor that causes a migratory response of
ECs (Lamalice et al., 2007). In our system, an external media
reservoir was not used as the media in the chamber was sufficient
to keep the cells alive for a 7-day culture period. The bilayer tubes
were porous enough to enable the application of flow and the
diffusion of the media between the media the inside of the tube
and the media in the chamber, as shown in the time-lapse figure
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TABLE 1 | Comparison of current in vitro, ex vivo, and in vivo angiogenesis assays with the developed dynamic 3D angiogenesis model (– = absence, + = very low,
++ = low, +++ = low/medium, ++++ = medium, +++++ = medium/high, ++++++ = high).
Models Cost Ethical
concern
Reproducibility Special skill
requirement
Representation of
the physiological
angiogenesis
Duration of the
assay
References
In vitro Proliferation assays + – ++++++ + + ++/+++ Arbiser et al., 1998; Goodwin,
2007; Logie et al., 2010; Chiu
et al., 2012
Migration assays ++ – ++++++ + + + Kye et al., 2004; Logie et al.,
2010; Chiu et al., 2012
Tube formation
assays
++ – ++++ ++ + + Langenfeld and Langenfeld,
2004; Hung et al., 2007;
DeCicco-Skinner et al., 2014
3D dynamic
angiogenesis model
+ – ++++++ + ++/+++ ++ This study
Ex vivo Aortic ring/arch
assays
++ ++ +++ +++ +++ +++ Masson et al., 2002;
Auerbach and
Muthukkaruppan, 2012;
Baker et al., 2012
Retinal assay ++ ++ +++ +++ +++ ++ Sawamiphak et al., 2010;
Rezzola et al., 2013
In vivo In-ovo CAM assay ++ +++ +++ ++++ ++++ ++++ Vargas et al., 2007; Lokman
et al., 2012
Ex-ovo CAM assay ++ +++ +++ +++++ ++++ ++++ Aldemir Dikici et al., 2019a;
Dikici et al., 2019a,b; Mangir
et al., 2019
Dorsal skinfold
chamber assay
++++++ ++++++ ++ ++++++ ++++++ +++ Rücker et al., 2006; Laschke
et al., 2011
Sponge/Matrigel®
plug assay
++++++ ++++++ ++ ++++++ ++++++ ++++ Akhtar et al., 2002; Malinda,
2009
Corneal assay +++++ ++++++ ++ +++++ +++++ +++ Ziche et al., 1994; Arbiser
et al., 1998
Zebrafish assay ++ +++ ++ ++++ ++++ ++ Serbedzija et al., 1999; Nicoli
and Presta, 2007
(Figure 8A), the trypan blue dye was spread over the chamber
by this time and as there was no volume change observed in
the chamber, which indicates the liquid transport both from the
tube to the chamber and the chamber to the tube. But as this
transportation takes time, even after 10min trypan blue did not
cover the top of the tube. During the culture of HAECs in the
tubes, there was a continuous nutrient consumption in the inside
of the tube by the cells, which probably created a concentration
gradient between the circulating media (in the tube) and the
media in the chamber. As the circulatingmedia (represented with
trypan blue, Figures 8B,C) was comparably exhausted in terms
of supplemented angiogenic agents (2dDR and VEGF) compared
to media in the chamber (represented with water, Figures 8B,C),
themigration of HAECs from the inner surface of the electrospun
tube toward outside PolyHIPE layer can be explained by the
chemotactic stimulus for ECs due to the abundance of the drugs
in the chamber when compared with the inner tube where
perfusion occurs.
The current study makes a novel contribution to the literature
on understanding the dose-dependent angiogenic activity of
2dDR in vitro and by demonstrating a novel 3D model which
can be used to study angiogenesis in vitro in a 3D dynamic
environment. Herein, we showed that the 3D in vitro model
we developed gave results consistent with the established
angiogenesis assays for testing of the angiogenic effect of 2dDR
in comparison with VEGF. Our model enables users to monitor
cell proliferation and migration simultaneously under more
physiologically relevant conditions. Our bilayer tubular system
will also enable the future co-culture of ECs with another cell
line; for example, seeding bone cells into the PolyHIPE tube
while ECs are in the electrospun tube to study angiogenesis in
bone tissue engineering. This new 3D dynamic model will be
suitable for studying several aspects of angiogenesis. For instance,
quantitative assessment of angiogenesismarkersmay give a better
insight into the response of ECs to an external stimulus and
to flow.
CONCLUSION
In the present study, we showed that 100µM 2dDR could
be used to promote HAEC proliferation, migration and tube
formation in vitro and was almost as effective as 80 ng/mL
VEGF. A 3D bilayer dynamic system which enables one
to study angiogenesis in vitro was successfully fabricated
by combining electrospinning and emulsion templating. The
angiogenic activity of 2dDR was evaluated in the 3D dynamic
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system compared to VEGF under static and flow conditions.
Both agents improved EC density in the tube and the
outgrowth of cells under either static or 2 dyn/cm2 shear
stress conditions.
The results demonstrate that 2dDR at 100µM can essentially
be used as an alternative to VEGF in every aspect of
EC biology we studied including their assessment in a
3D dynamic system developed in this study which has
considerable potential to be used for the assessment of the
angiogenic potential of different flow regimes and pro-angiogenic
agents in vitro.
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